11 Best Value Stocks to Buy Now
On February 7, Richard Bernstein, the CEO of Richard Bernstein Advisors, joined 'The Exchange' on CNBC to discuss the current state of the equity markets and his firm's macro-driven investment strategy...
Glaxosmithkline Plc (GSK)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 33,195,985 | $1,627,931,136 | +4% | 0.56% |
| 2. | Holocene Advisors Brandon Haley | 8,116,527 | $398,034,484 | +15% | 0.84% |
| 3. | Eversept Partners Kamran Moghtaderi | 2,679,721 | $131,413,518 | +27% | 6.62% |
| 4. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 2,265,186 | $111,084,721 | 0.07% | |
| 5. | Point72 Asset Management Steve Cohen | 1,474,951 | $72,331,597 | 0.08% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 68,517,969 | $3,360,121,200 | 1.81% | |
| 2. | 67,469,409 | $3,308,699,817 | 0.17% | |
| 3. | 25,130,160 | $1,232,383,047 | 0.93% | |
| 4. | 12,557,487 | $615,819,163 | 0.11% | |
| 5. | 8,480,546 | $415,886,000 | 0.07% |
News See All
GSK plc (GSK) Q4 Results Topped Forecasts as Specialty Medicines Jump 17%
GSK plc (NYSE:GSK) ranks among the best undervalued European stocks to buy now.
11 Undervalued European Stocks to Buy Now
European markets closed at a record high on February 11, with gains in commodity-related companies offsetting declines in technology and financials, while traders digested a solid US jobs report.
GSK plc (NYSE:GSK) Q4 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, a warm welcome to the GSK Full Year 2025 Results Call. I'm delighted to be joined today by Luke Miels, Nina Mojas, Deborah Waterhouse, Tony Wood and Julie Brown.
Jefferies Reaffirms a Buy Rating on GSK plc (GSK) - Here's Why
GSK plc (NYSE:GSK) is one of the best performing pharma stocks in 2025. Jefferies reaffirmed a Buy rating on GSK plc (NYSE:GSK) on January 7 and set a price target of $55.60.
10 Best Performing Pharma Stocks in 2025
On January 8, Michael Yee, global head of biotech research at UBS, appeared on CNBC’s ‘Squawk on the Street’ to discuss his bullish outlook on biopharma stocks in 2026 and the pharma M&A outlook...
Why is GSK plc (GSK) One of the Best Affordable Healthcare Stocks to Buy Now?
GSK plc (NYSE:GSK) is one of the best affordable healthcare stocks to buy now.
10 Best Affordable Healthcare Stocks to Buy Now
According to him, this has been a year where certain areas of healthcare, particularly those related to health spend or real significant turnarounds in business, have performed pretty well, allowing certain...
HSBC Sees Pharma Poised to Outperform in 2026, Lifts GSK Target
On December 10, HSBC analyst Rajesh Kumar raised the firm’s price target on GSK plc (NYSE:GSK) to 1,500 GBp from 1,200 GBp and kept a Reduce rating on the shares.
15 Global Dividend Stocks to Diversify Your Portfolio
Dividend stocks are back in focus, and not just in the US, but investors around the world are leaning into income again, and the data shows why.
Hedge Fund Resource Center